SCHEMBL15819502

SCHEMBL15819502

COc1cc2nc(Cc3ccccc3)nc(O)c2cc1OC

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 2/20 0.59
▸ PDE3B Q13370 1/20 0.54
▸ PDE3A Q14432 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.47
▸ ELANE P08246 2/20 0.46
▸ ABCB1 P08183 1/20 0.46
▸ MAPK1 P28482 1/20 0.45
▸ WHR1 P49842 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ NSD2 O96028 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ PRNP P04156 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15819473 0.83 NTSR1 (0.59) NTSR1PDE3BPDE3AKDM4EELANE
SCHEMBL4085302 0.81 SMN1; SMN2 (0.52) KDM4EMAPK1ALDH1A1GAAPOLB
SCHEMBL15819106 0.79 NTSR1 (0.49) NTSR1PDE3BPDE3AKDM4EELANE
SCHEMBL19385357 0.77 ELANE (0.55) PDE3BPDE3AKDM4EELANENSD2
SCHEMBL15819418 0.77 NTSR1 (0.51) NTSR1PDE3BPDE3AKDM4EELANE
SCHEMBL30170771 0.76 ELANE (0.41) NTSR1PDE3BPDE3AKDM4EELANE
SCHEMBL15502326 0.76 ELANE (0.53) ELANEABCB1NSD2
SCHEMBL15819572 0.75 HTT (0.41) NTSR1PDE3BPDE3AKDM4EELANE
SCHEMBL15818956 0.75 NTSR1 (0.52) NTSR1PDE3BPDE3AKDM4EELANE
SCHEMBL31037841 0.74 DHPS (0.62) NTSR1MAPK1ALDH1A1L3MBTL1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2938608-B1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD BURNHAM MED RES INST (US) 2021-08-04 — — EP disclosed
US-9868707-B2 Small molecule agonists of neurotensin receptor 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2018-01-16 — — US disclosed
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 DUKE UNIVERSITY (US) 2015-11-19 — — US disclosed
EP-2938608-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford-Burnham Medical Research Institute (US) 2015-11-04 — — EP disclosed
WO-2014100501-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 NTSR1, NTSR2, VIPR1 NTSR1 1/4885PDE3B 1119/4885PDE3A 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback